GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Obio Technology (shanghai) Corp Ltd (SHSE:688238) » Definitions » PB Ratio

Obio Technology (shanghai) (SHSE:688238) PB Ratio : 1.90 (As of Apr. 10, 2025)


View and export this data going back to 2022. Start your Free Trial

What is Obio Technology (shanghai) PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2025-04-10), Obio Technology (shanghai)'s share price is ¥5.48. Obio Technology (shanghai)'s Book Value per Share for the quarter that ended in Sep. 2024 was ¥2.88. Hence, Obio Technology (shanghai)'s PB Ratio of today is 1.90.

The historical rank and industry rank for Obio Technology (shanghai)'s PB Ratio or its related term are showing as below:

SHSE:688238' s PB Ratio Range Over the Past 10 Years
Min: 1.3   Med: 3.02   Max: 12.37
Current: 1.9

During the past 10 years, Obio Technology (shanghai)'s highest PB Ratio was 12.37. The lowest was 1.30. And the median was 3.02.

SHSE:688238's PB Ratio is ranked better than
53.94% of 1283 companies
in the Biotechnology industry
Industry Median: 2.04 vs SHSE:688238: 1.90

During the past 12 months, Obio Technology (shanghai)'s average Book Value Per Share Growth Rate was -12.10% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 24.10% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 43.10% per year.

During the past 10 years, the highest 3-Year average Book Value Per Share Growth Rate of Obio Technology (shanghai) was 69.50% per year. The lowest was -10.10% per year. And the median was 26.40% per year.

Back to Basics: PB Ratio


Obio Technology (shanghai) PB Ratio Historical Data

The historical data trend for Obio Technology (shanghai)'s PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Obio Technology (shanghai) PB Ratio Chart

Obio Technology (shanghai) Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 4.33 2.83

Obio Technology (shanghai) Quarterly Data
Jun18 Dec18 Jun19 Dec19 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.90 2.83 1.92 1.54 1.87

Competitive Comparison of Obio Technology (shanghai)'s PB Ratio

For the Biotechnology subindustry, Obio Technology (shanghai)'s PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Obio Technology (shanghai)'s PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Obio Technology (shanghai)'s PB Ratio distribution charts can be found below:

* The bar in red indicates where Obio Technology (shanghai)'s PB Ratio falls into.


;
;

Obio Technology (shanghai) PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Obio Technology (shanghai)'s PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Sep. 2024)
=5.48/2.879
=1.90

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Obio Technology (shanghai)  (SHSE:688238) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Obio Technology (shanghai) PB Ratio Related Terms

Thank you for viewing the detailed overview of Obio Technology (shanghai)'s PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Obio Technology (shanghai) Business Description

Traded in Other Exchanges
N/A
Address
Lane 908, Ziping Road, Building 19, International Medical Park, Pudong New Area, Shanghai, CHN, 201321
Obio Technology (shanghai) Corp Ltd is a biotechnology company focusing on the field of gene therapy, focusing on the development of gene therapy vectors, gene function research, drug targets and efficacy for the basic research of gene therapy Research and other CRO services, and provide CDMO services such as process development and testing, IND-CMC pharmaceutical research, and clinical sample GMP production for the research and development of genetic drugs.
Executives
You Qing Rui Directors, senior managers
Pan Jun Yi Director
Yang Jia Li Core technical personnel

Obio Technology (shanghai) Headlines

No Headlines